Skip to main content
Hit enter to search or ESC to close
Close Search
search
account
Menu
Products & Portal
CNSide™
CNSide™
Biomarker / Test Summary
Order a Test
Portal Login
Technology
Overview
Publications
Patents
Clinical Trials
BioPharma Services
Billing
Billing Policy
Pay My Bill
Payment Instructions
Payment Portal
Company
About Biocept
Investors
Management Team
Board of Directors
Careers
Contact
search
account
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases
September 21, 2023
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
September 08, 2023
Biocept to Participate in the H.C. Wainwright Global Investment Conference
September 05, 2023
Close Menu
Products & Portal
CNSide™
CNSide™
Biomarker / Test Summary
Order a Test
Portal Login
Technology
Overview
Publications
Patents
Clinical Trials
BioPharma Services
Billing
Billing Policy
Pay My Bill
Payment Instructions
Payment Portal
Company
About Biocept
Investors
Management Team
Board of Directors
Careers
Contact
